Cost-effectiveness of genotyping in inherited arrhythmia syndromes: are we getting value for the money?
Wilde
Arthur A M
AA
Pinto
Yigal M
YM
D001145:Arrhythmias, Cardiac / Q000175:diagnosis* / Q000191:economics / Q000235:genetics*; D054537:Atrioventricular Block / Q000175:diagnosis / Q000235:genetics; D053840:Brugada Syndrome / Q000175:diagnosis / Q000235:genetics; D003362:Cost-Benefit Analysis; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000191:economics; D017048:Health Care Costs; D006292:Health Priorities; D006297:Health Services Accessibility; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007473:Ion Channels / Q000235:genetics*; D008133:Long QT Syndrome / Q000175:diagnosis / Q000235:genetics; D008403:Mass Screening / Q000191:economics / Q000379:methods*; D018579:Patient Selection; D010641:Phenotype; D011237:Predictive Value of Tests; D017180:Tachycardia, Ventricular / Q000175:diagnosis / Q000235:genetics
D007473:Ion Channels